Abstract
Cytolysis syndrome is a clinical and laboratory complex characterized by an increase in the levels of intracellular biocatalysts of blood transaminases in response to the action of damaging factors, accompanied by their defect and fatal. Cytolysis syndrome can be triggered by infectious and parasitic diseases, metabolic disorders, as well as drug lesions due to polypragmasia. The study of new and effective methods of correction of cytolytic syndrome is an urgent task of clinicians. Vitaminamino acid complex (VAC) "Vitam", due to the presence of a balanced amount of vitamins, amino acids, trace elements and glucose, compensates for the deficiency of these biologically active substances in the body of animals that occurs during hepatosis. The article presents data on the study of the effectiveness of the drug "Vitam" in 45 cats with established cytolytic liver syndrome. The dynamics of biochemical changes in the blood serum of cats with daily administration of the drug for ten days is shown. There was a decrease in the activity of AlAT, AsAT, GGT and LDH, whose indicators reached normal after the course of treatment. The expediency of using the drug "Vitam" in cats with cytolytic syndrome and with subclinical manifestation as therapeutic and metabolic therapy has been established.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.